AVIEW LCS vs eMurmur ID
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your organization requires an AI-powered solution for comprehensive cardiopulmonary assessment from low-dose CT scans. This tool is ideal for enhancing lung cancer screening programs by automatically detecting and analyzing lung nodules, while also providing integrated analysis for COPD and coronary artery calcification from the same scan.
View AVIEW LCS →Choose eMurmur ID if…
Choose eMurmur ID if you need an AI-driven mobile and cloud solution for real-time heart murmur detection and classification using electronic stethoscopes. This tool is best suited for clinicians seeking immediate decision support at the point of care or in telehealth settings to quickly identify and differentiate between pathologic and innocent heart murmurs.
View eMurmur ID →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | eMurmur ID |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud, Mobile, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDAVIEW LCS focuses on integrating into existing radiology PACS/RIS workflows and automating complex analyses, which enhances usability for radiologists. However, eMurmur ID's mobile-first approach, real-time feedback, and intuitive interface for clinicians at the point of care offer a more immediate and accessible user experience for a broader range of healthcare providers.
Clinical Value
AVIEW LCSAVIEW LCS provides a comprehensive assessment by analyzing lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, offering quantitative metrics and automated follow-up comparisons. This multi-disease detection capability across critical conditions offers a broader and deeper clinical impact compared to eMurmur ID's focused heart murmur detection.
Pricing & Value
AVIEW LCSBoth tools require direct contact for pricing, making a direct cost comparison impossible. However, AVIEW LCS's ability to provide integrated analysis for three major disease areas (lung cancer, COPD, and coronary artery calcification) from a single scan suggests a higher potential for comprehensive value and efficiency gains for a healthcare institution.
Enterprise Readiness
AVIEW LCSBoth are FDA cleared, HIPAA compliant, and offer flexible deployment. However, AVIEW LCS demonstrates superior enterprise readiness through its explicit and deep integration with PACS/RIS systems, DICOM compatibility, and a wider array of deployment options including dedicated hardware and virtualization, which are crucial for large-scale radiology IT environments.
Innovation
AVIEW LCSAVIEW LCS's innovation lies in its integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, including automated nodule comparison in follow-up scans. This multi-modal assessment from one imaging study represents a significant advancement in streamlining complex diagnostic workflows and comprehensive patient assessment.
Support & Docs
TieNeither the provided structured facts nor web searches yielded specific details about the depth, accessibility, or quality of support and documentation for either AVIEW LCS or eMurmur ID, beyond the general availability of contact information on their respective company websites. Therefore, it is not possible to distinguish between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | eMurmur ID |
|---|---|---|
| Primary Clinical Focus | Lung Cancer Screening & Cardiopulmonary Assessment (Lung Nodules, COPD, Coronary Artery Calcification) | Heart Murmur Detection and Classification |
| Core AI Application | Automated lung nodule detection and analysis, emphysema quantification, coronary artery calcification scoring | AI-based analytics for heart murmur detection and classification |
| Input Data Source | Low-dose CT scan | Third-party electronic stethoscope |
| Specific Feature: Reporting/Classification | Lung-RADS classification and reporting, comprehensive automated report generation | Identifies pathologic and innocent heart murmurs, absence of murmur, S1, S2 heart sounds |
| Specific Feature: Cardiac Assessment | Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass) | Not specified |
| Specific Feature: Device Integration | Integration with PACS/RIS and third-party platforms | Operates with 3rd party electronic stethoscopes (e.g., Littmann 3200, Thinklabs One) |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and eMurmur ID.